Taoka Chemical Company, Limited

TSE:4113 Stok Raporu

Piyasa değeri: JP¥13.2b

Taoka Chemical Company Gelecekteki Büyüme

Future kriter kontrolleri 4/6

Taoka Chemical Company is forecast to grow earnings and revenue by 28.3% and 8.7% per annum respectively. EPS is expected to grow by 28.3% per annum. Return on equity is forecast to be 9.2% in 3 years.

Anahtar bilgiler

28.3%

Kazanç büyüme oranı

28.3%

EPS büyüme oranı

Chemicals kazanç büyümesi12.7%
Gelir büyüme oranı8.7%
Gelecekteki özkaynak getirisi9.2%
Analist kapsamı

Low

Son güncelleme30 Oct 2024

Gelecekteki son büyüme güncellemeleri

Recent updates

Is Taoka Chemical Company (TSE:4113) Using Too Much Debt?

Oct 30
Is Taoka Chemical Company (TSE:4113) Using Too Much Debt?

Why Investors Shouldn't Be Surprised By Taoka Chemical Company, Limited's (TSE:4113) 27% Share Price Surge

Sep 03
Why Investors Shouldn't Be Surprised By Taoka Chemical Company, Limited's (TSE:4113) 27% Share Price Surge

Taoka Chemical Company (TSE:4113) Has Announced A Dividend Of ¥9.00

Aug 21
Taoka Chemical Company (TSE:4113) Has Announced A Dividend Of ¥9.00

Taoka Chemical Company (TSE:4113) Will Pay A Dividend Of ¥9.00

Jul 25
Taoka Chemical Company (TSE:4113) Will Pay A Dividend Of ¥9.00

Taoka Chemical Company (TSE:4113) Has Affirmed Its Dividend Of ¥9.00

Jul 11
Taoka Chemical Company (TSE:4113) Has Affirmed Its Dividend Of ¥9.00

Taoka Chemical Company (TSE:4113) Has Announced A Dividend Of ¥9.00

Mar 12
Taoka Chemical Company (TSE:4113) Has Announced A Dividend Of ¥9.00

Taoka Chemical Company (TSE:4113) Is Paying Out A Dividend Of ¥9.00

Feb 27
Taoka Chemical Company (TSE:4113) Is Paying Out A Dividend Of ¥9.00

Kazanç ve Gelir Büyüme Tahminleri

TSE:4113 - Analistlerin gelecek tahminleri ve geçmiş finansal verileri (JPY Millions )
TarihGelirKazançlarSerbest Nakit AkışıFaaliyetlerden NakitAvg. Analist Sayısı
3/31/202735,4001,9501,314N/A1
3/31/202632,8001,600766N/A1
3/31/202529,5001,100628N/A1
9/30/202428,795999N/AN/AN/A
6/30/202428,7161,199N/AN/AN/A
3/31/202428,5448202,4863,628N/A
12/31/202328,800577N/AN/AN/A
9/30/202329,713578-1112,432N/A
6/30/202329,452206N/AN/AN/A
3/31/202330,166310-2,8501,478N/A
12/31/202230,825749N/AN/AN/A
9/30/202230,783918-4,306-497N/A
6/30/202231,5971,589N/AN/AN/A
3/31/202232,3742,063-3,405-1,329N/A
12/31/202132,9942,272N/AN/AN/A
9/30/202133,0112,6831,0413,348N/A
6/30/202133,1422,703N/AN/AN/A
3/31/202132,0572,6153,1605,218N/A
12/31/202030,3412,564N/AN/AN/A
9/30/202029,6632,5342,7914,516N/A
6/30/202027,7882,203N/AN/AN/A
3/31/202025,6711,8971,3402,848N/A
12/31/201924,8641,556N/AN/AN/A
9/30/201924,6921,5241,2542,475N/A
6/30/201924,5841,608N/AN/AN/A
3/31/201924,4571,8192,2833,588N/A
12/31/201824,3152,001N/AN/AN/A
9/30/201823,4141,7041,6374,337N/A
6/30/201822,7501,552N/AN/AN/A
3/31/201821,8431,363N/A3,069N/A
12/31/201722,4841,546N/AN/AN/A
9/30/201721,3921,492N/A3,133N/A
6/30/201721,7061,396N/AN/AN/A
3/31/201721,0001,262N/A1,858N/A
12/31/201619,911995N/AN/AN/A
9/30/201621,1691,058N/A1,454N/A
6/30/201620,5601,036N/AN/AN/A
3/31/201620,9161,110N/A2,400N/A
12/31/201520,855878N/AN/AN/A
9/30/201520,106725N/A1,666N/A
6/30/201519,810419N/AN/AN/A
3/31/201519,779323N/A623N/A
12/31/201419,564395N/AN/AN/A
9/30/201418,702172N/A1,067N/A
6/30/201417,897215N/AN/AN/A
3/31/201417,920236N/A2,394N/A
12/31/201317,271219N/AN/AN/A

Analist Gelecek Büyüme Tahminleri

Kazançlar ve Tasarruf Oranları: 4113's forecast earnings growth (28.3% per year) is above the savings rate (0.3%).

Kazançlar ve Piyasa: 4113's earnings (28.3% per year) are forecast to grow faster than the JP market (8.9% per year).

Yüksek Büyüme Kazançları: 4113's earnings are expected to grow significantly over the next 3 years.

Gelir ve Pazar: 4113's revenue (8.7% per year) is forecast to grow faster than the JP market (4.2% per year).

Yüksek Büyüme Geliri: 4113's revenue (8.7% per year) is forecast to grow slower than 20% per year.


Hisse Başına Kazanç Büyüme Tahminleri


Gelecekteki Özkaynak Getirisi

Gelecekteki ROE: 4113's Return on Equity is forecast to be low in 3 years time (9.2%).


Büyüyen şirketleri keşfedin